Covid-19 Test Device

I led development of a novel Point-Of-Care, sample-to-answer, low-cost diagnostic device for Covid-19 detection directly from a nasopharyngeal swab.
The project was successfully funded through Phase 1 of the NIH’s RADx program (~$1.2M in funding) and was the key technology behind a spin-out company, AmplifiDX ( https://www.amplifidx.com ). IP was filed.
The system components and all associated data was created for and are the sole property of Wainamics, Inc
Details have been redacted/omitted due to NDA/IP concerns.